<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Market Performance on FinanClub</title>
    <link>https://finan.club/tags/market-performance/</link>
    <description>Recent content in Market Performance on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 03 Jan 2024 09:02:35 +0000</lastBuildDate><atom:link href="https://finan.club/tags/market-performance/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>IMGN</title>
      <link>https://finan.club/us/imgn/</link>
      <pubDate>Wed, 03 Jan 2024 09:02:35 +0000</pubDate>
      
      <guid>https://finan.club/us/imgn/</guid>
      <description>score:69
Chances: ImmunoGen has shown strong performance compared to its sector so far this year.The acquisition of ImmunoGen fills an immediate need and provides additional benefits.ImmunoGen is an innovative biotech company working on important research and developments in the medical world.The projected fair value for ImmunoGen is promising based on Free Cash Flow to Equity.</description>
    </item>
    
  </channel>
</rss>
